MedTech News
.................... by Andrew Celentano
New AI tool could replace costly cancer gene expression profiling
A team led by Cedars-Sinai Health Sciences University investigators has created a faster, cheaper way to determine the genes expressed in cancerous tumors. The AI-based tool, which they describe in the journal Cell, could make personalized cancer treatment available to more patients.
3D-printed ceramic implants that mimic human bone could enable patient-matched repair
Researchers at Tampere University, Finland, have developed a groundbreaking 3D-printed ceramic implant material that closely mimics real human bone.
Heat-treated probiotic may protect sperm from BPA-linked damage, rat study suggests
A research team led by Visiting Professor Yukiko Minamiyama of the Graduate School of Medicine at OMU investigated whether a paraprobiotic material derived from the lactic acid bacterium Enterococcus faecalis (known as FK‑23) protects against the sperm toxicity caused by BPA.
Stretchy implants could stick to arteries to treat high blood pressure
According to researchers at Penn State, tiny devices that gently shock one of the body’s most critical arteries could offer effective treatment.
FDA clears Glooko’s cloud-based insulin dosing platform
Ideating on Glooko’s existing EndoTool system, the cloud-based version is designed to support more scalable deployment across hospital settings.
Real-time diagnostic smart dressing patch could end fear of diabetic foot amputation
A research team has developed a wireless, battery-free optoelectronic multi-modal sensor patch for diabetic ulcer management. It can monitor wound conditions in real time.
Lab-designed molecule offers hope for celiac disease sufferers
A research project led by the Institute for Research in Nutrition and Food Safety (INSA) and the Faculty of Pharmacy and Food Sciences at the University of Barcelona, together with the Molecular Biology Institute of Barcelona (IBMB) of the CSIC (which stands for Consejo Superior de Investigaciones Científicas), has successfully designed and tested a gluten-degrading molecule that is a promising ally in the management of celiac disease, an autoimmune
AI platform decodes how cells ‘talk’ in cancer, Alzheimer’s and other complex diseases
Scientists at Houston Methodist have developed an artificial intelligence platform that can decode how cells communicate inside the human body, opening a window into conditions such as Alzheimer’s disease, cancer, and potentially accelerating the search for new treatments.